Find Research Outputs

Search in all content

Filters for Publications

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2017
  • 2016

Author

  • Yumei Ye
2016

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

Birnbaum, Y., Bajaj, M., Qian, J. & Ye, Y., Aug 1 2016, In : BMJ Open Diabetes Research and Care. 4, 1, e000227.

Research output: Contribution to journalArticle

35 Scopus citations
2019
Open Access
2 Scopus citations

The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion Injury

Siebert, V., Allencherril, J., Ye, Y., Wehrens, X. H. T. & Birnbaum, Y., Aug 15 2019, In : Cardiovascular Drugs and Therapy. 33, 4, p. 489-498 10 p.

Research output: Contribution to journalArticle

6 Scopus citations
2017

Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ Agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia

Chen, Y., Chen, H., Birnbaum, Y., Nanhwan, M. K., Bajaj, M., Ye, Y. & Qian, J., Mar 1 2017, In : Diabetes and Vascular Disease Research. 14, 2, p. 152-162 11 p.

Research output: Contribution to journalArticle

3 Scopus citations
2016

Type 2 diabetes and cardiovascular disease: A metabolic overview of recent clinical trials

Birnbaum, Y., Ye, Y. & Bajaj, M., 2016, (Accepted/In press) In : Journal of Diabetes and its Complications.

Research output: Contribution to journalArticle

1 Scopus citations
2017
72 Scopus citations

Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice

Ye, Y., Nylander, S. & Birnbaum, Y., Nov 28 2017, (Accepted/In press) In : Cardiovascular Drugs and Therapy. p. 1-12 12 p.

Research output: Contribution to journalArticle

7 Scopus citations
2020

Does Inhibition of Nuclear Factor Kappa B Explain the Protective Effect of Ticagrelor on Myocardial Ischemia-Reperfusion Injury?

Birnbaum, Y., Ye, Y. & Perez-Polo, J. R., Feb 1 2020, In : Journal of cardiovascular pharmacology. 75, 2, p. 108-111 4 p.

Research output: Contribution to journalArticle

2019

DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome

Birnbaum, Y., Tran, D., Bajaj, M. & Ye, Y., Sep 1 2019, In : Basic Research in Cardiology. 114, 5, 35.

Research output: Contribution to journalArticle

9 Scopus citations
2016

Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine

Birnbaum, Y., Birnbaum, G. D., Birnbaum, I., Nylander, S. & Ye, Y., Dec 1 2016, In : Cardiovascular Drugs and Therapy. 30, 6, p. 539-550 12 p.

Research output: Contribution to journalArticle

19 Scopus citations
2020

Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay

Chen, H., Tran, D., Yang, H. C., Nylander, S., Birnbaum, Y. & Ye, Y., Aug 1 2020, In : Cardiovascular Drugs and Therapy. 34, 4, p. 443-461 19 p.

Research output: Contribution to journalArticle

1 Scopus citations

Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy

Ye, Y., Birnbaum, Y., Widen, S., Zhang, Z., Zhu, S., Bajaj, M. & Chen, H., 2020, (Accepted/In press) In : Cardiovascular Drugs and Therapy.

Research output: Contribution to journalArticle

2016

Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury

Qian, J., Chen, H., Birnbaum, Y., Nanhwan, M. K., Bajaj, M. & Ye, Y., Feb 10 2016, (Accepted/In press) In : Cardiovascular Drugs and Therapy. p. 1-13 13 p.

Research output: Contribution to journalArticle

7 Scopus citations